Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8548646 | 0.90 | AGTR1 (0.39) | AGTR1AGTR2 | |
| SCHEMBL8548764 | 0.84 | AGTR1 (0.65) | AGTR1AGTR2 | |
| SCHEMBL6606977 | 0.81 | AGTR1 (0.67) | AGTR1AGTR2 | |
| SCHEMBL9296448 | 0.79 | AGTR1 (0.52) | AGTR1AGTR2 | |
| SCHEMBL6607561 | 0.78 | AGTR1 (0.66) | AGTR1AGTR2 | |
| SCHEMBL6609591 | 0.78 | AGTR1 (0.66) | AGTR1AGTR2 | |
| SCHEMBL8549174 | 0.77 | AGTR1 (0.46) | AGTR1AGTR2 | |
| SCHEMBL6605207 | 0.76 | AGTR1 (0.53) | AGTR1AGTR2 | |
| SCHEMBL8552543 | 0.76 | AGTR1 (0.38) | AGTR1AGTR2 | |
| SCHEMBL6610737 | 0.74 | AGTR1 (0.56) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0588299-B1 | 1,2,4-Oxadiazolyl- or 1,2,4-thiadiazolyl-biphenyl derivatives as angiotensin II antagonists | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-07-01 | — | — | EP | disclosed |
| EP-0829479-A1 | Heterocyclic compounds and their use as angiotensin II antagonists | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-03-18 | — | — | EP | disclosed |
| US-5500427-A | ANGIOTENSIN II ANTAGONISTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-03-19 | — | — | US | disclosed |
| EP-0588299-A2 | 1,2,4-Oxadiazolyl- or 1,2,4-thiadiazolyl-biphenyl derivatives as angiotensin II antagonists | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-03-23 | — | — | EP | disclosed |